It contains more than half a million people’s genomes, paired with clinical records and wearable tech data. That gives ...

Eli Lilly and Regeneron are among the first seven companies the FDA has selected for its PreCheck Pilot Program, CNBC has ...

NT-proBNP is one of the most widely used tested biomarkers in medicine. Doctors rely on it to diagnose and monitor heart ...

The concept of biological age, distinct from chronological age, is gaining public traction, though often misinterpreted.

Rare As One, founded by pediatrician Priscilla Chan, wife of Meta CEO Mark Zuckerberg, has been giving grants to patients and ...

TRexBio Announces Pipeline Progress, Naming TRB-071 as a CD30 Agonist for Immune-Mediated Diseases and Advancement of Lilly-Partnered TRB-051 ...

Artificial intelligence programs can spot patterns in electrocardiograms that humans miss. Now, one program is going to be ...

Men have nipples because embryos are sexually neutral for their first six weeks. Here's the developmental blueprint behind ...

FDA’s draft “plausible mechanism” framework gives individualized genetic therapies a clearer path to market, but questions remain, write experts at Morrison Foerster.

A biotech company and a U.S. government agency announced on Thursday a plan to create an archive of living cells and genomic ...

The Barcelonan, an international reference in cancer research, has just received European funding of 2.5 million euros to ...

Monopar Therapeutics Inc. ('Monopar” or the 'Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, today ...